NCT06965686 · RECRUITING

Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk

This trial is developing and pilot-testing a brief behavioral program called PERI-MIND for perimenopausal women who have a family history of Alzheimer's or dementia. The goal is to help them manage fear and anxiety about developing dementia themselves. This is a Phase NA development and feasibility study — meaning researchers are still building and refining the tool, not yet testing whether it prevents or treats any disease.

You may qualify if

  • Female sex at birth
  • Aged between 40-58 years
  • Late perimenopause or early post-menopause
  • Elevated dementia risk characterized by first degree relative with diagnosis of Alzheimer's disease or another dementia

You're excluded if

  • Diagnosis of Mild Cognitive Impairment, Alzheimer's or another dementia
  • Diagnosis of other chronic illness or condition that affects cognition (e.g., Axis I psychiatric disorders such as schizophrenia or mood disorders, neurological disorders such as stroke, cancer, traumatic brain injury)
  • Inadequate vision or hearing to engage with intervention materials
  • Unable or unwilling to provide informed consent
  • Iatrogenic menopause (i.e., due to surgery)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-02-05

View full record on ClinicalTrials.gov

All APOE4 clinical trials